Riskpilot← Back to searchSign inGet full accessNärtandvården Tyringe AB
ABActiveOrg 5569066417Malmövägen 15Dental practice care activities · NACE 8623Est. 20128 employees
Revenue 2024
SEK 7,4M
-1% vs 2023
EBITDA margin
5.8%
-49% vs 2023
Equity ratio
45.5%
Financial strength
Net profit 2024
SEK 225K
+7720% vs 2023
| Revenue | SEK 7,4M | -1% |
| EBITDA | SEK 429K | -49% |
| Net profit | SEK 225K | +7720% |
| Total assets | SEK 2,3M | -1% |
| Equity | SEK 1M | +28% |
| Employees | 8 | — |
Legal name
Närtandvården Tyringe AB
Org number
5569066417
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
12 oktober 2012
Share capital
SEK 50 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva tandvårdsverksamhet och därmed förenlig verksamhet.
Address
Malmövägen 15
Phone
+46760462526
Email
otl02038@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 043 | 6 155 | 6 219 | 7 399 | 7 351 |
| Staff expenses | — | — | −3 598 | −4 263 | −4 495 |
| EBITDA | 786 | 820 | 704 | 845 | 429 |
| Depreciation & amort. | −22 | −47 | −72 | −90 | −115 |
| EBIT | 764 | 773 | 632 | 755 | 314 |
| Net financials | −2 | −1 | −2 | 10 | 2 |
| Profit before tax | 572 | −388 | 406 | 4 | 291 |
| Tax | −119 | −0 | 5 | −1 | −66 |
| Net profit | 453 | −388 | 411 | 3 | 225 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 908 | 1 254 | 1 533 | 2 278 | 2 259 |
| Equity | 777 | 389 | 800 | 803 | 1 028 |
| Long-term debt | 68 | 5 | 0 | — | — |
| Short-term debt | 873 | 860 | 733 | 1 475 | 1 231 |
| Total debt | 941 | 865 | 733 | 1 475 | 1 231 |
EBITDA margin
5.8%
This company
15.8%
Market median
-63% vs market
20202024
Equity ratio
45.5%
This company
38.2%
Market median
+19% vs market
20202024
Return on equity
21.9%
This company
18.4%
Market median
+19% vs market
20202024
Net profit margin
3.1%
This company
8.1%
Market median
-62% vs market
20202024
Asset turnover
3.25×
This company
1.12×
Market median
+190% vs market
20202024
Debt / equity
1.20×
This company
0.62×
Market median
-94% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BT Audit | Audit | 2021 |
| Former (1) | ||
JO Chief Auditor | Chief Auditor | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
TA | Board of Directors | 2020 |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tim Anle Holding AB
Närtandvården Tyringe AB Board members of Närtandvården Tyringe AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Thomas Axelsson | Audit | 0 companies |
| Jens Oscar Simon Bertling | Chief Auditor | 0 companies |
| Roza Makhaeva | Deputy Board Member | 0 companies |
| Khamzat Makhaev | Deputy Board Member | 0 companies |
| Tim Anle | Board of Directors | 0 companies |